BILLIONTOONE INC CL A (BLLN) Fundamental Analysis & Valuation

NASDAQ:BLLN • US0901681058

Current stock price

86.97 USD
+7.54 (+9.49%)
Last:

This BLLN fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

3

1. BLLN Profitability Analysis

1.1 Basic Checks

  • In the past year BLLN was profitable.
  • In the past year BLLN had a positive cash flow from operations.
BLLN Yearly Net Income VS EBIT VS OCF VS FCFBLLN Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2023 2024 2025 0 20M -20M -40M -60M -80M

1.2 Ratios

  • The Return On Assets of BLLN (0.46%) is comparable to the rest of the industry.
  • With a Return On Equity value of 0.61%, BLLN perfoms like the industry average, outperforming 53.00% of the companies in the same industry.
  • Looking at the Return On Invested Capital, with a value of 2.16%, BLLN is in line with its industry, outperforming 44.00% of the companies in the same industry.
Industry RankSector Rank
ROA 0.46%
ROE 0.61%
ROIC 2.16%
ROA(3y)-18.81%
ROA(5y)N/A
ROE(3y)-98.5%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
BLLN Yearly ROA, ROE, ROICBLLN Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2023 2024 2025 0 -50 -100 -150 -200 -250

1.3 Margins

  • BLLN has a Profit Margin (0.96%) which is comparable to the rest of the industry.
  • BLLN has a better Operating Margin (5.25%) than 65.00% of its industry peers.
  • BLLN has a better Gross Margin (68.32%) than 87.00% of its industry peers.
Industry RankSector Rank
OM 5.25%
PM (TTM) 0.96%
GM 68.32%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
BLLN Yearly Profit, Operating, Gross MarginsBLLN Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2023 2024 2025 0 50 -50 -100

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

7

2. BLLN Health Analysis

2.1 Basic Checks

  • With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), BLLN is destroying value.
  • The number of shares outstanding for BLLN has been increased compared to 1 year ago.
  • BLLN has a better debt/assets ratio than last year.
BLLN Yearly Shares OutstandingBLLN Yearly Shares OutstandingYearly Shares Outstanding 2023 2024 2025 10M 20M 30M 40M
BLLN Yearly Total Debt VS Total AssetsBLLN Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2023 2024 2025 200M 400M 600M

2.2 Solvency

  • BLLN has an Altman-Z score of 16.65. This indicates that BLLN is financially healthy and has little risk of bankruptcy at the moment.
  • BLLN has a better Altman-Z score (16.65) than 98.00% of its industry peers.
  • The Debt to FCF ratio of BLLN is 4.30, which is a neutral value as it means it would take BLLN, 4.30 years of fcf income to pay off all of its debts.
  • BLLN has a Debt to FCF ratio of 4.30. This is in the better half of the industry: BLLN outperforms 62.00% of its industry peers.
  • A Debt/Equity ratio of 0.12 indicates that BLLN is not too dependend on debt financing.
  • Looking at the Debt to Equity ratio, with a value of 0.12, BLLN is in the better half of the industry, outperforming 74.00% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.12
Debt/FCF 4.3
Altman-Z 16.65
ROIC/WACC0.24
WACC8.86%
BLLN Yearly LT Debt VS Equity VS FCFBLLN Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2023 2024 2025 0 100M 200M 300M 400M

2.3 Liquidity

  • BLLN has a Current Ratio of 11.69. This indicates that BLLN is financially healthy and has no problem in meeting its short term obligations.
  • With an excellent Current ratio value of 11.69, BLLN belongs to the best of the industry, outperforming 98.00% of the companies in the same industry.
  • BLLN has a Quick Ratio of 11.32. This indicates that BLLN is financially healthy and has no problem in meeting its short term obligations.
  • With an excellent Quick ratio value of 11.32, BLLN belongs to the best of the industry, outperforming 98.00% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 11.69
Quick Ratio 11.32
BLLN Yearly Current Assets VS Current LiabilitesBLLN Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2023 2024 2025 100M 200M 300M 400M 500M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

5

3. BLLN Growth Analysis

3.1 Past

  • BLLN shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 114.79%, which is quite impressive.
  • Looking at the last year, BLLN shows a very strong growth in Revenue. The Revenue has grown by 99.97%.
EPS 1Y (TTM)114.79%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%103.94%
Revenue 1Y (TTM)99.97%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%-37.05%

3.2 Future

  • Based on estimates for the next years, BLLN will show a very strong growth in Earnings Per Share. The EPS will grow by 119.28% on average per year.
  • The Revenue is expected to grow by 33.15% on average over the next years. This is a very strong growth
EPS Next Y198.71%
EPS Next 2Y137.03%
EPS Next 3Y119.28%
EPS Next 5YN/A
Revenue Next Year47.74%
Revenue Next 2Y38.66%
Revenue Next 3Y33.15%
Revenue Next 5YN/A

3.3 Evolution

BLLN Yearly Revenue VS EstimatesBLLN Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2023 2024 2025 2026 2027 2028 200M 400M 600M
BLLN Yearly EPS VS EstimatesBLLN Yearly EPS VS EstimatesYearly EPS VS Estimates 2025 2026 2027 2028 0.5 1 1.5

More info and screens

Find the best growth stocksShow best growing peers

1

4. BLLN Valuation Analysis

4.1 Price/Earnings Ratio

  • Based on the Price/Earnings ratio of 621.21, the valuation of BLLN can be described as expensive.
  • BLLN's Price/Earnings ratio is a bit more expensive when compared to the industry. BLLN is more expensive than 61.00% of the companies in the same industry.
  • BLLN is valuated expensively when we compare the Price/Earnings ratio to 27.95, which is the current average of the S&P500 Index.
  • Based on the Price/Forward Earnings ratio of 178.54, the valuation of BLLN can be described as expensive.
  • Based on the Price/Forward Earnings ratio, BLLN is valued a bit more expensive than 65.00% of the companies in the same industry.
  • The average S&P500 Price/Forward Earnings ratio is at 38.68. BLLN is valued rather expensively when compared to this.
Industry RankSector Rank
PE 621.21
Fwd PE 178.54
BLLN Price Earnings VS Forward Price EarningsBLLN Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 200 400 600

4.2 Price Multiples

  • Based on the Enterprise Value to EBITDA ratio, BLLN is valued a bit more expensive than the industry average as 69.00% of the companies are valued more cheaply.
  • 64.00% of the companies in the same industry are cheaper than BLLN, based on the Price/Free Cash Flow ratio.
Industry RankSector Rank
P/FCF 255.09
EV/EBITDA 155.65
BLLN Per share dataBLLN EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 2 4 6 8 10

4.3 Compensation for Growth

  • The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
  • BLLN's earnings are expected to grow with 119.28% in the coming years. This may justify a more expensive valuation.
PEG (NY)3.13
PEG (5Y)N/A
EPS Next 2Y137.03%
EPS Next 3Y119.28%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. BLLN Dividend Analysis

5.1 Amount

  • No dividends for BLLN!.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

BLLN Fundamentals: All Metrics, Ratios and Statistics

BILLIONTOONE INC CL A

NASDAQ:BLLN (4/20/2026, 8:00:02 PM)

86.97

+7.54 (+9.49%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)03-04
Earnings (Next)05-06
Inst Owners28.08%
Inst Owner Change14.6%
Ins Owners19.11%
Ins Owner Change-43.63%
Market Cap4.00B
Revenue(TTM)305.11M
Net Income(TTM)2.92M
Analysts84.29
Price Target125.29 (44.06%)
Short Float %8.1%
Short Ratio5.35
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-26.75%
Min EPS beat(2)-80.59%
Max EPS beat(2)27.08%
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)1
Avg Revenue beat(2)3.46%
Min Revenue beat(2)-1.12%
Max Revenue beat(2)8.04%
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-9.2%
PT rev (3m)-9.2%
EPS NQ rev (1m)56.07%
EPS NQ rev (3m)29.82%
EPS NY rev (1m)69.57%
EPS NY rev (3m)80.41%
Revenue NQ rev (1m)0.19%
Revenue NQ rev (3m)6.43%
Revenue NY rev (1m)0.27%
Revenue NY rev (3m)8.76%
Valuation
Industry RankSector Rank
PE 621.21
Fwd PE 178.54
P/S 13.1
P/FCF 255.09
P/OCF 162.55
P/B 8.33
P/tB 8.33
EV/EBITDA 155.65
EPS(TTM)0.14
EY0.16%
EPS(NY)0.49
Fwd EY0.56%
FCF(TTM)0.34
FCFY0.39%
OCF(TTM)0.54
OCFY0.62%
SpS6.64
BVpS10.44
TBVpS10.44
PEG (NY)3.13
PEG (5Y)N/A
Graham Number5.7357 (-93.4%)
Profitability
Industry RankSector Rank
ROA 0.46%
ROE 0.61%
ROCE 2.74%
ROIC 2.16%
ROICexc 14.27%
ROICexgc 14.27%
OM 5.25%
PM (TTM) 0.96%
GM 68.32%
FCFM 5.14%
ROA(3y)-18.81%
ROA(5y)N/A
ROE(3y)-98.5%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score7
Asset Turnover0.48
Health
Industry RankSector Rank
Debt/Equity 0.12
Debt/FCF 4.3
Debt/EBITDA 2.51
Cap/Depr 129.12%
Cap/Sales 2.92%
Interest Coverage 3.45
Cash Conversion 107.25%
Profit Quality 536.93%
Current Ratio 11.69
Quick Ratio 11.32
Altman-Z 16.65
F-Score7
WACC8.86%
ROIC/WACC0.24
Cap/Depr(3y)103.65%
Cap/Depr(5y)N/A
Cap/Sales(3y)5.02%
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)114.79%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%103.94%
EPS Next Y198.71%
EPS Next 2Y137.03%
EPS Next 3Y119.28%
EPS Next 5YN/A
Revenue 1Y (TTM)99.97%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%-37.05%
Revenue Next Year47.74%
Revenue Next 2Y38.66%
Revenue Next 3Y33.15%
Revenue Next 5YN/A
EBIT growth 1Y133.99%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year598.28%
EBIT Next 3Y162.93%
EBIT Next 5YN/A
FCF growth 1Y133.51%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y159.44%
OCF growth 3YN/A
OCF growth 5YN/A

BILLIONTOONE INC CL A / BLLN Fundamental Analysis FAQ

What is the ChartMill fundamental rating of BILLIONTOONE INC CL A (BLLN) stock?

ChartMill assigns a fundamental rating of 4 / 10 to BLLN.


Can you provide the valuation status for BILLIONTOONE INC CL A?

ChartMill assigns a valuation rating of 1 / 10 to BILLIONTOONE INC CL A (BLLN). This can be considered as Overvalued.


What is the profitability of BLLN stock?

BILLIONTOONE INC CL A (BLLN) has a profitability rating of 3 / 10.


Can you provide the financial health for BLLN stock?

The financial health rating of BILLIONTOONE INC CL A (BLLN) is 7 / 10.